SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Catalytica Energy Systems, Inc. (CESI) -- Ignore unavailable to you. Want to Upgrade?


To: Liatris Spicata who wrote (1437)1/12/2000 12:45:00 PM
From: Dan B.  Respond to of 1514
 
Thanks for the news. Xonon sales have commenced prior to this UL approval, and of course the Company is profitable beforehand. UL approval can only boost confidence of future potential buyers of Xonon combustion equipped products. I remember the analyst prediction of over 40 a share of several years ago. It didn't happen, but I think CTAL could easily go there over the next couple of years, if not this year, if/when sales announcements begin adding up.

Dan B



To: Liatris Spicata who wrote (1437)1/20/2000 2:55:00 PM
From: Liatris Spicata  Respond to of 1514
 
New Clinical Trial Packaging Services

biz.yahoo.com

Doesn't seem like a big deal, but as of a few minutes ago the stock was up 1 7/16 to 13 1/2. Low of the day was 12 1/16.